Skip to main content
Caplight Logo









Hyprevention

Hyprevention

Private
New York City, New YorkHealthcare & Life Scienceshttps://hypreventionusa.com/

Last Round

Series B

Apr 3, 2024

Total Funding Raised

$21.42M

Company Overview

Hyprevention is a medical technology company that develops, manufactures, and sells implantable medical devices designed to reinforce bones weakened by osteoporosis or cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthopedic implantsvertebral augmentationminimally invasive surgeryspine surgerybone cementstrutplastyvertebroplastyosteoporosis treatmentpathological fracturemedical device manufacturerorthopedic hardwarespinal fracture repairinterventional radiologyPEEK implants

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hyprevention Comparables

Compare Hyprevention with similar companies based on industry and business-model similarity.

Hyprevention comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Joline GmbH & Co. KG
75%
Halma plc
75%
Merit Medical Systems Inc
75%

Hyprevention Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 3, 2024
Series AFeb 28, 2022
Series ASep 28, 2020
SeedDec 16, 2015

Hyprevention Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 28, 2020

    Completed a Series A funding round.

  • Dec 16, 2015

    $820K raised from BeAngels and others.

Hyprevention Filings

Explore SEC and related filing metadata, where available.

Hyprevention filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hyprevention's valuation, stock price, and market status.

Is Hyprevention a public or private company?

Hyprevention is a private company.

What is the current stock price of Hyprevention?

Hyprevention is a private company with no public stock price. No recent secondary market data is available.

How much is Hyprevention worth (valuation)?

Valuation information for Hyprevention is not publicly available.

Can I buy Hyprevention stock?

Hyprevention shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hyprevention's last funding round?

Hyprevention's most recent funding round was Series B on April 3, 2024.

Who are the main investors in Hyprevention?

Key investors in Hyprevention include Yellowstone Holding AG, Business Angels Switzerland, Cercle des Investisseurs de Genève, BeAngels.

Will Hyprevention IPO soon?

No public IPO plans have been announced for Hyprevention.

How can I track Hyprevention secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hyprevention's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2010
Last FundingApr 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?